Causes of Disease Can Be Revealed By Metabolic Fingerprinting, According to 'Metabolome-Wide' Study
News Apr 21, 2008
Your metabolic 'fingerprint' can reveal much about the possible causes of major diseases, according to the first 'metabolome-wide' association study ever carried out, published in the journal Nature.
The study provides new insights into the possible causes of high blood pressure, a leading cause of heart disease and stroke, by analyzing the metabolic fingerprints of 4,630 adults in the UK, USA, China and Japan, from their urine samples.
Metabolic fingerprinting looks at the relative levels of many different metabolites, which are the products of metabolism, in a person's blood or urine. Metabolites act as markers which can reveal a lot about how diet and lifestyle contribute to risks for certain diseases.
The research shows that adults in the UK and USA, which have similar incidences of high blood pressure and cardiovascular problems, have similar metabolic fingerprints, reflecting similar lifestyles in spite of their geographical distance from one another.
In contrast, although adults in Japan and China have similar genetic profiles, they have very different metabolic fingerprints from one another and from adults in the UK and USA, and also have major differences in the incidence of many diseases.
Japanese people living in the USA have metabolic fingerprints that resemble other people in the USA, and dissimilar fingerprints to their counterparts living in Japan. This shows that lifestyle is a dominant feature in determining metabolism.
Professor Jeremy Nicholson, one of the authors of the research from the Department of Biomolecular Medicine at Imperial College London, said:
"Our research illustrates how metabolome-wide association studies can give us important clues as to the causes of major health problems such as high blood pressure. Metabolic profiling can tell us how specific aspects of a person's diet and how much they drink are contributing to their risks for certain diseases, and these are things which we can't investigate by looking at a person's DNA. What is really important is that we can test out our new hypotheses directly, in a way that is not easy with genetic biomarkers".
Professor Paul Elliott, a co-author of the research from the Department of Epidemiology and Public Health at Imperial College, added: "The flip-side of this is that whereas a person can't alter their DNA, they can change their metabolic profile by changing their diet and lifestyle.
This means that as we figure out where the problems lie, we should also be able to show people ways to reduce their risk of certain diseases."
The new study reveals that people with increased levels of the amino acid alanine, which is found in many foods but which is particularly high in animal protein, have higher blood pressure and also increased energy intake, levels of dietary cholesterol, and body mass index.
People with increased levels of the metabolite formate have lower blood pressure and increased energy intake. Formate arises from the action of microbes in the gut or as a product of metabolism in the body. Increased levels of hippurate, a by-product of metabolism by microbes in the gut, are found in people with lower blood pressure, lower levels of alcohol intake, and higher levels of dietary fibre.
"Non-Gene" Mutations May Hold Answers to Neurodevelopmental DisordersNews
Mutations in non-coding regions of the genome, which don't contain genes, but control the regulation of other genes, may hold answers to rare developmental disorders that affect the nervous system.READ MORE
Majority of European Wolves Have Dog DNANews
The wolf may not often act like man's best friend, but a new study has found that the majority of wild wolves in Europe contain chunks of dog DNA. The finding is causing scientists to rethink what constitutes a wolfdog hybrid and how we approach conservation of keystone wolf populations.READ MORE
Neuroblastoma Biomarker Research Advances TreatmentNews
Neuroblastoma, a childhood cancer, is treatable in less than half of aggressive cases, but new RNA biomarkers may help identify high-risk patients faster and lead to better prognosis.READ MORE